Showing results (31-40 of 173) with videos related to
Sort By:
Pageof 18
L'Encephale|February 11, 2000
[Abuse of tianeptine. A case report]P Vandel, W Regina, B Bonin, et al.Medical Hypotheses|December 1, 1996
CYP 2D6 PM phenotype hypothesis of antidepressant extrapyramidal side-effectsP Vandel, B Bonin, S Vandel, et al.La Revue Du Praticien|November 1, 1994
[Value of plasma assays of psychotropic drugs]T François, B Bonin, S Vandel, et al.Biological Psychiatry|August 1, 1986
Lack of seasonal variation in platelet [3H]imipramine binding in humansA M Galzin, H Lôo, D Sechter, et al.Pharmacopsychiatria|January 1, 1982
High-affinity 3H-imipramine binding: a new biological marker in depressionS Z Langer, E Zarifian, M Briley, et al.L'Encephale|July 4, 2008
[The therapeutic alliance in the initial stages of the management of depression by the general practitioner]P Frémont, A Gérard, D Sechter, et al.Psychopharmacology|January 1, 1981
High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteersR Raisman, D Sechter, M S Briley, et al.L'Encephale|June 30, 2000
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]K Reggiani, P Vandel, E Haffen, et al.Pageof 18